Dose‐response Trial of Lactoferrin in Patients with Chronic Hepatitis C

Hepatitis C virus (HCV) is one of the most common causes of chronic hepatitis. Interferon is presently the only effective treatment for chronic hepatitis C (CH‐C), though its effectiveness is limited. Lactoferrin (LF), which is an 80‐kDa, iron‐binding glycoprotein, has several biological activities...

全面介紹

Na minha lista:
書目詳細資料
發表在:Jpn J Cancer Res
Main Authors: Okada, Shuichi, Tanaka, Katsuaki, Sato, Tosiya, Ueno, Hideki, Saito, Satoru, Okusaka, Takuji, Sato, Keiko, Yamamoto, Seiichiro, Kakizoe, Tadao
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2002
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927129/
https://ncbi.nlm.nih.gov/pubmed/12359061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2002.tb02484.x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍